Remove 2004 Remove Communication Remove Pharmaceutical Companies
article thumbnail

Reality Bites: Disappointment in the R&D Sector

Pharmaceutical Technology

When TS Eliot said humankind cannot stand very much reality, he obviously did not consider the virtual kind which is now heralded as the key for curing and preventing disease and picked as the potential lifeline for R&D in the pharmaceutical industry. “There is a real threat the pharmaceutical R&D industry could move offshore.”

article thumbnail

Primate models in pharma: What the future holds

Pharmaceutical Technology

This is to ensure patient safety, as outlined in The Medicines for Human Use (Clinical Trials) Regulations 2004. Current regulations for preclinical research In the UK, current regulation requires that all new medicines and vaccines be tested on animal models in preclinical studies, before being tested in humans in clinical trials.

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

Sustainability: Corporate Ambition, Governance, & Accelerated Delivery

ISPE

A collaborative mindset must prevail between pharmaceutical companies, suppliers, and regulators and include strategic partnerships that go beyond the pharmaceutical sector so we can move together to a more sustainable future. The risks are equally applicable to both privately owned and publicly traded companies.

article thumbnail

CMC Requirements for New Drug Registration in Latin America

ISPE

In an era when the world is accelerating the development of drugs and targeted medicines using innovative technologies, pharmaceutical companies still face registration hurdles for well-characterized molecules because of redundant or additional local regulatory requirements. April 2004. 012166 from 2004. 2013/C 223/01.